A novel drug, retatrutide, is sparking considerable anticipation in the field of obesity treatment . This two-pronged injectable therapy works by mimicking the effects of two gut hormones, GLP-1 and GIP, which inherently regulate hunger and promote feelings of fullness . Early clinical investigat